Overview
Lymphangioleiomyomatosis (LAM) is a rare idiopathic disease affecting women that was first described by von Stossel in 1937. LAM is characterized by nonneoplastic peribronchial, perivascular, and perilymphatic proliferation of atypical smooth muscle resulting in vascular and airway obstruction, cyst formation, and a progressive decline in lung function. Typical radiographic findings of reticular interstitial lung disease, recurrent pneumothoraces, and recurrent chylous effusions have been described.[1, 2, 3, 4, 5] (See the image below.)
Lymphangioleiomyomatosis. Subtle interstitial reticular pattern in a female patient with slightly increased lung volumes. An association with renal angiomyolipomas is observed in as many as 50% of patients. The disease may occur sporadically or as part of the tuberous sclerosis complex (TSC) that includes mental retardation, seizures, and skin abnormalities.[1] However, less than 5% of patients with TSC have pulmonary disease. When pulmonary features of LAM are identified in males, consider a diagnosis of TSC. Angiomyolipomas are seen in the images below.[2, 6, 7, 8]
Lymphangioleiomyomatosis. Sagittal view of left kidney showing large fat-containing angiomyolipoma (arrows) arising from lower pole.
Lymphangioleiomyomatosis. Large angiomyolipoma of left kidney with recent hemorrhage. Preferred examination
With clinical suspicion, lymphangioleiomyomatosis (LAM) has been diagnosed on the basis of compatible chest radiograph, pulmonary function tests (PFTs), and computed tomography (CT) scan findings. CT scanning is the most specific imaging test for diagnosing LAM.[9, 10, 11]
Limitations of techniques
Chest radiograph and pulmonary function test (PFT) findings, while suggestive of lymphangioleiomyomatosis (LAM), can be nonspecific and may be normal despite the presence of symptoms. Plain radiography may not detect the thin-walled cysts identified on CT and may underestimate the extent of the disease. PFT results vary depending on the extent of disease. CT scanning, and especially high-resolution CT (HRCT) scanning, may reveal distinct findings that obviate the need for biopsy; however, diseases such as emphysema occasionally must be excluded. CT detection of a renal angiomyolipoma or chylous ascites further supports the diagnosis.
Radiography
Initial film is abnormal in more than 95% of patients with LAM.
A symmetrical, diffuse, reticular interstitial pattern (shown in the image below), caused by summation of multiple cyst walls, is typical.
Lymphangioleiomyomatosis. Subtle interstitial reticular pattern in a female patient with slightly increased lung volumes. If Kerley B lines are present, they may be the result of interstitial edema related to lymphatic obstruction. Multiple cysts become visible as they enlarge. Occasionally, patients may present with pneumothorax or chylous pleural effusion.
LAM is one of the few interstitial diseases in which lung volumes are maintained or increased. Cystic fibrosis and Langerhans cell histiocytosis (eosinophilic granuloma) share this feature.
A high index of clinical suspicion for lymphangioleiomyomatosis (LAM) should be maintained in women of childbearing age who present with recurrent pneumothoraces, when chylous effusion or an interstitial pattern on chest radiograph is not identified.
False positives/negatives
Large lung volumes and interstitial disease on plain film also can be seen with Langerhans cell histiocytosis, sarcoidosis, and extrinsic allergic alveolitis. Occasionally, emphysema presents with a similar pattern as a result of summation of widespread small bullae.
Computed Tomography
Initial CT scan findings are almost always abnormal despite a normal chest radiograph.
The typical appearance of LAM on HRCT is of thin-walled, air-containing cysts ranging from 2-50 mm in a diffuse symmetric pattern. The cyst walls range from 2 mm to an almost imperceptible thickness, and the cysts usually are round, but they may be polygonal. Intervening lung tissue appears normal. LAM cysts are shown on the image below.
Lymphangioleiomyomatosis. A high-resolution CT in a female patient showing numerous well-defined, thin-walled cysts evenly distributed throughout both lungs. CT scanning also may reveal lymphadenopathy, small pneumothoraces, alveolar hemorrhages, and septal lines. Ground-glass opacity, if seen, may result from hemosiderosis or proliferation of smooth muscle.
CT scan of the abdomen may detect lymphadenopathy or renal angiomyolipoma. The kidneys should be included in the initial imaging if LAM or tuberous sclerosis complex (TSC) is suggested.
In Langerhans cell histiocytosis and in neurofibromatosis, cysts are seen predominantly in the upper lung zones. In addition, most patients with Langerhans cell histiocytosis have small pulmonary nodules initially, and cyst walls are not entirely uniform.
Magnetic Resonance Imaging
A single case report of lymphangioleiomyomatosis (LAM) describes the appearance of thin-walled cysts on spin-echo of the lung.
Ultrasonography
Ultrasonography has not been proven useful for the diagnosis of LAM or of any other interstitial lung disease. An angiomyolipoma is seen in the ultrasonogram below.[10]
Lymphangioleiomyomatosis. Sagittal view of left kidney showing large fat-containing angiomyolipoma (arrows) arising from lower pole. Nuclear Imaging
In most patients with LAM, aerosol ventilation-perfusion scintigraphy reveals a speckled pattern of uptake on ventilation images. This appears distinct from the central clumping seen with poor aerosolization. The speckled pattern is believed to result from focal areas of activity on cyst walls by adherent aerosolized particles. The extent of the speckling seems to correlate to disease extent as determined by chest radiographs, PFTs, and CT scans.[9]
Degree of confidence
Specificity is unknown, although it is possible that a severe pattern of speckling is specific for LAM. Other lung diseases that produce cysts also may produce a speckled pattern.
Hohman DW, Noghrehkar D, Ratnayake S. Lymphangioleiomyomatosis: A review. Eur J Intern Med. Jul 2008;19(5):319-24. [Medline].
Chorianopoulos D, Stratakos G. Lymphangioleiomyomatosis and tuberous sclerosis complex. Lung. Jul-Aug 2008;186(4):197-207. [Medline].
Glasgow CG, Taveira-Dasilva AM, Darling TN, Moss J. Lymphatic involvement in lymphangioleiomyomatosis. Ann N Y Acad Sci. 2008;1131:206-14. [Medline].
Sullivan EJ. Lymphangioleiomyomatosis: a review. Chest. Dec 1998;114(6):1689-703. [Medline].
Urban T, Lazor R, Lacronique J, Murris M, Labrune S, Valeyre D, et al. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore). Sep 1999;78(5):321-37. [Medline].
Burger CD, McCormack FX. Variability in the prevalence of acute bronchoresponsiveness in different populations of patients with lymphangioleiomyomatosis. Chest. Jul 2008;134(1):217-8. [Medline].
Johnson S. Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms. Thorax. Mar 1999;54(3):254-64. [Medline].
Smolarek TA, Wessner LL, McCormack FX. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet. Apr 1998;62(4):810-5. [Medline].
Avila NA, Chen CC, Chu SC. Pulmonary lymphangioleiomyomatosis: correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests. Radiology. Feb 2000;214(2):441-6. [Medline].
Avila NA, Kelly JA, Chu SC. Lymphangioleiomyomatosis: abdominopelvic CT and US findings. Radiology. Jul 2000;216(1):147-53. [Medline].
Sundaram B, Gross BH, Oh E, Muller N, Myles JD, Kazerooni EA. Reader Accuracy and Confidence in Diagnosing Diffuse Lung Disease on High-Resolution Computed Tomography of the Lungs: Impact of Sampling Frequency. Acta Radiol. Jul 11 2008;1-6. [Medline].

